Untitled
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Recommendations regarding splenectomy in hereditary hemolytic anemias | Haematologica
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Haematologica, Volume 104, Issue 4 by Haematologica - Issuu
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Haematologica, Volume 105, Issue 7 by Haematologica - Issuu
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Vol. 102 No. 8 (2017): August, 2017 | Haematologica
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
Untitled
PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
Haematologica, Volume 106, Issue 5 by Haematologica - Issuu
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Haematologica, Volume 105, Issue 10 by Haematologica - Issuu
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
